A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals
- 28 July 2006
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 73 (1) , 50-59
- https://doi.org/10.1016/j.antiviral.2006.07.006
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Pandemics, Avian Influenza A (H5N1), and a Strategy for PharmacistsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United StatesJAMA, 2006
- Oseltamivir Resistance during Treatment of Influenza A (H5N1) InfectionNew England Journal of Medicine, 2005
- Evaluation of Division-Arrested Cells for Cell-Based High-Throughput Screening and ProfilingSLAS Discovery, 2005
- Pandemic Influenza: Are We Ready?Disaster Management & Response, 2005
- Mechanism of Action of T-705 against Influenza VirusAntimicrobial Agents and Chemotherapy, 2005
- Improving Consistency of Cell-Based Assays by Using Division-Arrested CellsASSAY and Drug Development Technologies, 2005
- Simple, Intuitive Calculations of Free Energy of Binding for Protein−Ligand Complexes. 2. Computational Titration and pH Effects in Molecular Models of Neuraminidase−Inhibitor ComplexesJournal of Medicinal Chemistry, 2003
- The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagenNature Medicine, 2000
- Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin TriphosphateAntimicrobial Agents and Chemotherapy, 1977